Position in MDXG
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$908,725
-$1,749,631 QoQ
Shares Held
236,033
-64.9% QoQ
Ownership
0.162%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#46
of 226 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in MDXG Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,789,681,375 across 562 Biotechnology names. MDXG ranks #269 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in MDXG
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $908,725 | 236,033 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $2,658,356 | 673,002 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $1,802,017 | 266,177 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $4,095,702 | 586,777 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,748,808 | 449,887 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,876,022 | 378,424 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $5,059,282 | 525,913 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,653,428 | 279,768 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $835,536 | 120,568 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,142,978 | 278,309 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $2,102,817 | 239,774 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $875,885 | 120,149 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $755,383 | 114,279 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $351,928 | 103,205 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $403,463 | 145,131 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $108,887 | 37,940 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $282,089 | 81,294 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $1,107,347 | 235,106 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,392,853 | 230,605 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $501,743 | 82,796 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $265,962 | 21,260 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $316,673 | 30,745 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $183,143 | 20,170 | Shares | Defined | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||